Health economics and health technology assessment: perspectives from Australia and New Zealand.

TitleHealth economics and health technology assessment: perspectives from Australia and New Zealand.
Publication TypeJournal Article
Year of Publication2012
AuthorsStreat S, Munn S
JournalCritical care clinics
Volume28
Issue1
Pagination125-33, vii
Date Published2012 Jan
ISSN1557-8232
KeywordsAustralia; Cost-benefit analysis; Decision Making, Organizational; Financing, Government; Health Care Rationing; Humans; New Zealand; Pharmaceutical Preparations; Technology Assessment, Biomedical
AbstractFormal health economics and health technology assessment (HTA)processes, including cost-effectiveness and cost-utility analysis, are variably used to inform decisions about public and private health service funding and service provision. In general, pharmaceuticals have been subject to more sophisticated health economic analyses and HTAs and for a longer time than either devices or procedures. HTA has been performed by a number of different entities. While HTA shares many common features across the world, its uses, approaches, applications,and impact differ throughout the world. This article will discuss some of the general attributes of HTA and will focus on its specific applications in Australia and New Zealand.
DOI10.1016/j.ccc.2011.10.008
Alternate JournalCrit Care Clin